AbbVie is a company that makes medicine. Some people who know a lot about businesses and medicine bought special things called options that let them bet on whether the price of AbbVie's stock will go up or down. They spent a lot of money doing this, so they must think something important is going to happen with AbbVie soon. People who watch these things noticed these big bets and want to tell others about it, so they can decide if they want to join in too. Read from source...

1. The title is misleading and sensationalized, implying that there is a frenzy or chaos around AbbVie's options, which may not be the case for ordinary investors. A more accurate title could be "AbbVie's Options Activity: What You Need to Know".
2. The article lacks proper citation and reference for its claims, making it difficult to verify the sources or check for accuracy. For example, where did the options scanner data come from? How was it collected and analyzed? Who are these "big-money traders" and how are they defined?
3. The article uses vague and subjective terms like "uncommon", "split between 40% bullish and 40%, bearish", and "whales" without explaining what they mean or how they are measured. These terms may create confusion or mislead readers into thinking that there is some secret knowledge or insider information behind the options trading patterns.
4. The article focuses too much on the predicted price range, volume, and open interest trends, which may not be relevant or reliable indicators for predicting AbbVie's stock performance. These data points may also fluctuate due to various factors unrelated to the company's fundamentals or prospects. A more balanced analysis should include other aspects like earnings, revenue, growth potential, competitive advantage, etc.

The article suggests that there is some unusual activity in AbbVie's options trading, with 10 uncommon trades detected by Benzinga's options scanner. This could indicate that the big-money traders have insider information or expect significant news or events related to AbbVie. The overall sentiment of these traders is split between bullish and bearish, which means there is no clear consensus on the direction of the stock price. Therefore, it would be risky to follow any specific investment recommendations based on this article alone. However, one possible strategy could be to monitor the volume and open interest trends for AbbVie's options, as they may provide clues about the liquidity and interest in the stock. Additionally, pay attention to the predicted price range of $135.0 to $165.0, as this is where whales have been targeting their trades. This could be a sign of potential resistance or support levels for the stock price.